3nr8
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3nr8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NR8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3NR8 FirstGlance]. <br> | <table><tr><td colspan='2'>[[3nr8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NR8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3NR8 FirstGlance]. <br> | ||
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3mtc|3mtc]], [[3n9v|3n9v]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3mtc|3mtc]], [[3n9v|3n9v]]</td></tr> |
- | <tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">INPPL1, SHIP2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">INPPL1, SHIP2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
- | <tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Alkaline_phosphatase Alkaline phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.1 3.1.3.1] </span></td></tr> | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Alkaline_phosphatase Alkaline phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.1 3.1.3.1] </span></td></tr> |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3nr8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3nr8 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3nr8 RCSB], [http://www.ebi.ac.uk/pdbsum/3nr8 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3nr8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3nr8 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3nr8 RCSB], [http://www.ebi.ac.uk/pdbsum/3nr8 PDBsum]</span></td></tr> |
- | <table> | + | </table> |
== Disease == | == Disease == | ||
[[http://www.uniprot.org/uniprot/SHIP2_HUMAN SHIP2_HUMAN]] Defects in INPPL1 may be a cause of susceptibility to type 2 diabetes mellitus non-insulin dependent (NIDDM) [MIM:[http://omim.org/entry/125853 125853]].<ref>PMID:12086927</ref> <ref>PMID:15687335</ref> Note=Genetic variations in INPPL1 may be a cause of susceptibility to metabolic syndrome. Metabolic syndrome is characterized by diabetes, insulin resistance, hypertension, and hypertriglyceridemia is absent. | [[http://www.uniprot.org/uniprot/SHIP2_HUMAN SHIP2_HUMAN]] Defects in INPPL1 may be a cause of susceptibility to type 2 diabetes mellitus non-insulin dependent (NIDDM) [MIM:[http://omim.org/entry/125853 125853]].<ref>PMID:12086927</ref> <ref>PMID:15687335</ref> Note=Genetic variations in INPPL1 may be a cause of susceptibility to metabolic syndrome. Metabolic syndrome is characterized by diabetes, insulin resistance, hypertension, and hypertriglyceridemia is absent. | ||
Line 29: | Line 29: | ||
Structural Basis for Phosphoinositide Substrate Recognition, Catalysis, and Membrane Interactions in Human Inositol Polyphosphate 5-Phosphatases.,Tresaugues L, Silvander C, Flodin S, Welin M, Nyman T, Graslund S, Hammarstrom M, Berglund H, Nordlund P Structure. 2014 Apr 2. pii: S0969-2126(14)00073-2. doi:, 10.1016/j.str.2014.01.013. PMID:24704254<ref>PMID:24704254</ref> | Structural Basis for Phosphoinositide Substrate Recognition, Catalysis, and Membrane Interactions in Human Inositol Polyphosphate 5-Phosphatases.,Tresaugues L, Silvander C, Flodin S, Welin M, Nyman T, Graslund S, Hammarstrom M, Berglund H, Nordlund P Structure. 2014 Apr 2. pii: S0969-2126(14)00073-2. doi:, 10.1016/j.str.2014.01.013. PMID:24704254<ref>PMID:24704254</ref> | ||
- | From | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
</div> | </div> | ||
== References == | == References == | ||
Line 37: | Line 37: | ||
[[Category: Alkaline phosphatase]] | [[Category: Alkaline phosphatase]] | ||
[[Category: Human]] | [[Category: Human]] | ||
- | [[Category: Arrowsmith, C H | + | [[Category: Arrowsmith, C H]] |
- | [[Category: Berg, S van der | + | [[Category: Berg, S van der]] |
- | [[Category: Berglund, H | + | [[Category: Berglund, H]] |
- | [[Category: Bountra, C | + | [[Category: Bountra, C]] |
- | [[Category: Collins, R | + | [[Category: Collins, R]] |
- | [[Category: Edwards, A M | + | [[Category: Edwards, A M]] |
- | [[Category: Flodin, S | + | [[Category: Flodin, S]] |
- | [[Category: Flores, A | + | [[Category: Flores, A]] |
- | [[Category: Graslund, S | + | [[Category: Graslund, S]] |
- | [[Category: Hammarstrom, M | + | [[Category: Hammarstrom, M]] |
- | [[Category: Johansson, I | + | [[Category: Johansson, I]] |
- | [[Category: Karlberg, T | + | [[Category: Karlberg, T]] |
- | [[Category: Kol, S | + | [[Category: Kol, S]] |
- | [[Category: Kotenyova, T | + | [[Category: Kotenyova, T]] |
- | [[Category: Kouznetsova, E | + | [[Category: Kouznetsova, E]] |
- | [[Category: Moche, M | + | [[Category: Moche, M]] |
- | [[Category: Nordlund, P | + | [[Category: Nordlund, P]] |
- | [[Category: Nyman, T | + | [[Category: Nyman, T]] |
- | [[Category: Persson, C | + | [[Category: Persson, C]] |
- | [[Category: | + | [[Category: Structural genomic]] |
- | [[Category: Schuler, H | + | [[Category: Schuler, H]] |
- | [[Category: Schutz, P | + | [[Category: Schutz, P]] |
- | [[Category: Siponen, M I | + | [[Category: Siponen, M I]] |
- | [[Category: Thorsell, A G | + | [[Category: Thorsell, A G]] |
- | [[Category: Tresaugues, L | + | [[Category: Tresaugues, L]] |
- | [[Category: Wahlberg, E | + | [[Category: Wahlberg, E]] |
- | [[Category: Weigelt, J | + | [[Category: Weigelt, J]] |
- | [[Category: Welin, M | + | [[Category: Welin, M]] |
[[Category: 5-trisphosphate 5-phosphatase 2]] | [[Category: 5-trisphosphate 5-phosphatase 2]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
Line 77: | Line 77: | ||
[[Category: Ship2]] | [[Category: Ship2]] | ||
[[Category: Signalling]] | [[Category: Signalling]] | ||
- | [[Category: Structural genomics consortium]] | ||
- | [[Category: Structural genomics consortium stockholm]] |
Revision as of 21:39, 3 January 2015
Crystal structure of human SHIP2
|
Categories: Alkaline phosphatase | Human | Arrowsmith, C H | Berg, S van der | Berglund, H | Bountra, C | Collins, R | Edwards, A M | Flodin, S | Flores, A | Graslund, S | Hammarstrom, M | Johansson, I | Karlberg, T | Kol, S | Kotenyova, T | Kouznetsova, E | Moche, M | Nordlund, P | Nyman, T | Persson, C | Structural genomic | Schuler, H | Schutz, P | Siponen, M I | Thorsell, A G | Tresaugues, L | Wahlberg, E | Weigelt, J | Welin, M | 5-trisphosphate 5-phosphatase 2 | Hydrolase | Inppl1 | Magnesium | Magnesium binding | Phosphatase | Phosphatidylinositol | Phosphatidylinositol-3 | Sgc | Ship-2 | Ship2 | Signalling